The Mechanism of Action of cTIND for Minimally Invasive Ischemic Incision  of the Prostate: In Vivo Study - ScienceDirect

The Mechanism of Action of cTIND for Minimally Invasive Ischemic Incision of the Prostate: In Vivo Study - ScienceDirect

4.6
(200)
Write Review
More
$ 20.00
Add to Cart
In stock
Description

Non-drug efflux function of ABCC5 promotes enzalutamide resistance

Targeting signaling pathways in prostate cancer: mechanisms and

ELK1 suppresses SYTL1 expression by recruiting HDAC2 in bladder

Prostate Surgery - an overview

Incisione Endoscopica Cervico-Prostatica: Indicazione e risultati

Immunoproteasome inhibition prevents progression of castration

The value of immediate postoperative intravesical epirubicin instillation as an adjunct to standard adjuvant treatment in intermediate and high-risk non–muscle-invasive bladder cancer: A preliminary results of randomized controlled trial - ScienceDirect

Cancers, Free Full-Text

Acute and late toxicity and preliminary outcomes report of